Dishman Pharmaceuticals allots 633137 equity shares upon conversion of FCCB

Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company at its meeting held on June 18, 2007 has allotted 6,33,137 equity shares of Rs 2/- each to the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion by the FCCB holders for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 2,500,000, into the equity shares of the Company.

Consequently, the paid-up equity share capital of the Company has increased from 7,30,99,470 equity shares of Rs 2/- each to 7,37,32,607 equity shares of Rs 2/- each.

Source : Equity Bulls

Keywords